Welcome to LookChem.com Sign In|Join Free

CAS

  • or

167263-10-7

Post Buying Request

167263-10-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1,4-Piperidinedicarboxylic acid, 4-(phenylmethyl)-, 1-(1,1-dimethylethyl) 4-ethyl ester

    Cas No: 167263-10-7

  • No Data

  • No Data

  • No Data

  • Chemical Co.Ltd
  • Contact Supplier

167263-10-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 167263-10-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,2,6 and 3 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 167263-10:
(8*1)+(7*6)+(6*7)+(5*2)+(4*6)+(3*3)+(2*1)+(1*0)=137
137 % 10 = 7
So 167263-10-7 is a valid CAS Registry Number.

167263-10-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Phenylmethyl)-1,4-piperidinedicarboxylic acid 1-(1,1-dimethylethyl) 4-ethyl ester

1.2 Other means of identification

Product number -
Other names 1-O-tert-butyl 4-O-ethyl 4-benzylpiperidine-1,4-dicarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:167263-10-7 SDS

167263-10-7Relevant articles and documents

NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS

-

Page/Page column 85, (2020/05/12)

Provided is a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, provided is a pharmaceutical composition comprising the said compound.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 191, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 204; 205, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 167263-10-7